Tissue-specific TAFs counteract polycomb to turn on terminal differentiation

Science

Volumn 310, Issue 5749, 2005, Pages 869-872

  Chen, Xin ^a   Hiller, Mark ^a,b   Sancak, Yasemin ^a,c   Fuller, Margaret T ^a,d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GOUCHER COLLEGE   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA; BACTERIOLOGY; BIOLOGICAL ORGANS; TISSUE CULTURE;

POLYCOMB TRANSCRIOTION; PRECURSOR; SILENCING MACHINERY; TERMINAL DIFFERENTIATION;

TISSUE;

POLYCOMB GROUP PROTEIN; TATA BINDING PROTEIN ASSOCIATED FACTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

BIOLOGY;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL FATE; CELL NUCLEUS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DROSOPHILA; GENE EXPRESSION; GENE SILENCING; GERM CELL; IMMUNOPRECIPITATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN LOCALIZATION; SEQUENCE HOMOLOGY; SPERMATOCYTE; STEM CELL; TESTIS; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION;

ANIMALS; CELL DIFFERENTIATION; CELL NUCLEOLUS; CHROMATIN IMMUNOPRECIPITATION; DROSOPHILA; DROSOPHILA PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MALE; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; SPERMATOCYTES; SPERMATOGENESIS; TATA-BINDING PROTEIN ASSOCIATED FACTORS; TESTIS; TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 27644467360     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1118101     Document Type: Article

References (22)

1. M. Hiller, T. Y. Lin, C. Wood, M. T. Fuller, Genes Dev. 15, 1021 (2001).
2. M. Hiller et al., Development 131, 5297 (2004).
3. H. White-Cooper, M. A. Schafer, L. S. Alphey, M. T. Fuller, Development 125, 125 (1998).
4. J. C. Pointud et al., J. Cell Sci. 116, 1847 (2003).
5. R. N. Freiman et al., Science 293, 2084 (2001).
6. K. Struhl, D. Kadosh, M. Keaveney, L. Kuras, Z. Moqtaderi, Cold Spring Harbor Symp. Quant. Biol. 63, 413 (1998).
7. A. J. Saurin, Z. Shao, H. Erdjument-Bromage, P. Tempst, R. E. Kingston, Nature 412, 655 (2001).
8. X. Chen, M. T. Fuller, unpublished data.
9. S. Dietzel, H. Niemann, B. Bruckner, C. Maurange, R. Paro, Chromosoma 108, 83 (1999).
10. E. M. Balicky, L. Young, T. L. Orr-Weaver, S. E. Bickel, Chromosoma 112, 231 (2004).
11. W. Fischle et al., Genes Dev. 17, 1870 (2003).
12. L. Wang et al., Mol. Cell 14, 637 (2004).
13. G. I. Dellino et al., Mol. Cell 13, 887 (2004).
14. N. J. Francis, R. E. Kingston, Nat. Rev. Mol. Cell Biol. 2, 409 (2001).
15. T. A. Milne et al., Mol. Cell 10, 1107 (2002).
16. J. Z. Maines, S. A. Wasserman, Nat. Cell Biol. 1, 171 (1999).
17. T. Y. Lin et al., Development 122, 1331 (1996).
18. V. Witte et al., Mol. Cell 13, 179 (2004).
19. V. Orlando, Cell 112, 599 (2003).
20. J. Lessard, G. Sauvageau, Nature 423, 2S5 (2003).
21. I. K. Park et al., Nature 423, 302 (2003).
22. XT109 flies; R. Paro for Pc-GFP flies and anti-Pc, R. Kingston and A. Saurin for anti-Pc and anti-Ph; S. Bickel for anti-dRing; R. Jones, H. White-Cooper, and K. Zhao for antibodies and technical assistance with ChIP; H. Chen for help with qPCR; T. Fellner for bringing to our attention the Pc-GFP results; and other Fuller lab members for helpful advice. Supported by a grant from NIH (1RO1GM61986). X.C. is a Leukemia and Lymphoma Society Special Fellow (grant LLS-3S98-06).